This role is responsible for driving end-to-end portfolio strategy, ensuring strong lifecycle management of existing brands, and leading excellence in launch readiness and execution across Malaysia & Singapore. Operating at the intersection of Commercial, Medical, Regulatory, Market Access, and Supply Chain, it ensures pipeline prioritization aligns with both local market dynamics and regional/global strategy, playing a pivotal role in maximizing portfolio value, accelerating access to medicines, and enabling sustainable long-term growth.